Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Full Stock Valuation Report is out for $WEED
Reports Include
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Download full Stock Valluation Report for $WEED HERE
ModusLink Global Solns $MLNK:NAS and Sierra Oncology $SRRA:NAS Trading at Less than Cash Value
MLNK:NAS ModusLink Global Solns
http://www.moduslink.com ModusLink Global Solns has 2200 employees and is headquartered in United States. ModusLink Global Solutions Inc provides supply chain management and marketing distribution services. The company develops and offers products and services to companies that are focused on e-commerce.
SRRA:NAS Sierra Oncology
https://www.sierraoncology.com Sierra Oncology has 53 employees and is headquartered in Canada. Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Check out the full list of Stcosk trading at less than cash value on our Daily Stocks Valuation Report HERE >>>>
ModusLink Global Solns $MLNK:NAS and Sierra Oncology $SRRA:NAS Trading at Less than Cash Value
MLNK:NAS ModusLink Global Solns
http://www.moduslink.com ModusLink Global Solns has 2200 employees and is headquartered in United States. ModusLink Global Solutions Inc provides supply chain management and marketing distribution services. The company develops and offers products and services to companies that are focused on e-commerce.
SRRA:NAS Sierra Oncology
https://www.sierraoncology.com Sierra Oncology has 53 employees and is headquartered in Canada. Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Check out the full list of Stcosk trading at less than cash value on our Daily Stocks Valuation Report HERE >>>>
ModusLink Global Solns $MLNK:NAS and Sierra Oncology $SRRA:NAS Trading at Less than Cash Value
MLNK:NAS ModusLink Global Solns
http://www.moduslink.com ModusLink Global Solns has 2200 employees and is headquartered in United States. ModusLink Global Solutions Inc provides supply chain management and marketing distribution services. The company develops and offers products and services to companies that are focused on e-commerce.
SRRA:NAS Sierra Oncology
https://www.sierraoncology.com Sierra Oncology has 53 employees and is headquartered in Canada. Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Check out the full list of Stcosk trading at less than cash value on our Daily Stocks Valuation Report HERE >>>>
Weekly Hot Stocks Outlook
Century Aluminum ($CENX) had a predictive moving average crossover to the upside in mid-August indicating a bullish trend. Traders know this when the blue line crosses above the black line. Additionally, the VantagePoint Neural Index moved to a “one” position indicating short term strength within the next 48 hours. Since that crossover, the market was up 21% in 5 trading days or $3.22 per share.
Allergan Inc ($AGN) had a predictive moving average crossover to the downside in late July indicating a bearish trend. The Neural Index also moved into the zero position confirming the trend’s weakness. Traders were able to short this market for profit using the VantagePoint predictive next day highs and lows. In 13 trading days, $PBI was down 18.52%, or $2.99 per share.
A. Schulman ($SHLM) had a crossover to the upside in early-August and the Neural Index moved to a “one” position indicating that the market was expected to strengthen over the short-term. This is a clear indication to traders that they can start going long in the market. In the 9 trading days since the uptrend, A. Schulman is up over 15% or $4.03 per share.
Fluor ($FLR) had a bearish crossover to the downside in July indicating to traders they should start taking shots. Despite the sideways movement, the blue line remained below the black line. Traders using VantagePoint knew this and could continue to short the market. In 26 trading days, the market was down over $8.00 per share or almost 18%.
Take-Two Interactive Software ($TTWO) has a bullish trend beginning in early July when that blue line crossed above the black line. Traders knew that they could start to go long because of these indicators. In 32 trading days, the market was up 27.39% or $20.29 per share.
Watch the Analysis & Outlook Video fr these Stocks HERE >>>>
Weekly Hot Stocks Outlook
Century Aluminum ($CENX) had a predictive moving average crossover to the upside in mid-August indicating a bullish trend. Traders know this when the blue line crosses above the black line. Additionally, the VantagePoint Neural Index moved to a “one” position indicating short term strength within the next 48 hours. Since that crossover, the market was up 21% in 5 trading days or $3.22 per share.
Allergan Inc ($AGN) had a predictive moving average crossover to the downside in late July indicating a bearish trend. The Neural Index also moved into the zero position confirming the trend’s weakness. Traders were able to short this market for profit using the VantagePoint predictive next day highs and lows. In 13 trading days, $PBI was down 18.52%, or $2.99 per share.
A. Schulman ($SHLM) had a crossover to the upside in early-August and the Neural Index moved to a “one” position indicating that the market was expected to strengthen over the short-term. This is a clear indication to traders that they can start going long in the market. In the 9 trading days since the uptrend, A. Schulman is up over 15% or $4.03 per share.
Fluor ($FLR) had a bearish crossover to the downside in July indicating to traders they should start taking shots. Despite the sideways movement, the blue line remained below the black line. Traders using VantagePoint knew this and could continue to short the market. In 26 trading days, the market was down over $8.00 per share or almost 18%.
Take-Two Interactive Software ($TTWO) has a bullish trend beginning in early July when that blue line crossed above the black line. Traders knew that they could start to go long because of these indicators. In 32 trading days, the market was up 27.39% or $20.29 per share.
Watch the Analysis & Outlook Video fr these Stocks HERE >>>>
Weekly Hot Stocks Outlook
Century Aluminum ($CENX) had a predictive moving average crossover to the upside in mid-August indicating a bullish trend. Traders know this when the blue line crosses above the black line. Additionally, the VantagePoint Neural Index moved to a “one” position indicating short term strength within the next 48 hours. Since that crossover, the market was up 21% in 5 trading days or $3.22 per share.
Allergan Inc ($AGN) had a predictive moving average crossover to the downside in late July indicating a bearish trend. The Neural Index also moved into the zero position confirming the trend’s weakness. Traders were able to short this market for profit using the VantagePoint predictive next day highs and lows. In 13 trading days, $PBI was down 18.52%, or $2.99 per share.
A. Schulman ($SHLM) had a crossover to the upside in early-August and the Neural Index moved to a “one” position indicating that the market was expected to strengthen over the short-term. This is a clear indication to traders that they can start going long in the market. In the 9 trading days since the uptrend, A. Schulman is up over 15% or $4.03 per share.
Fluor ($FLR) had a bearish crossover to the downside in July indicating to traders they should start taking shots. Despite the sideways movement, the blue line remained below the black line. Traders using VantagePoint knew this and could continue to short the market. In 26 trading days, the market was down over $8.00 per share or almost 18%.
Take-Two Interactive Software ($TTWO) has a bullish trend beginning in early July when that blue line crossed above the black line. Traders knew that they could start to go long because of these indicators. In 32 trading days, the market was up 27.39% or $20.29 per share.
Watch the Analysis & Outlook Video fr these Stocks HERE >>>>
Complete Stock Valuation Report for $XOM
Dowload Full Report on the below on $XOM HERE >>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Complete Stock Valuation Report for $XOM
Dowload Full Report on the below on $XOM HERE >>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
This Week’s Hot Stocks Outlook
Cincinnati Financial ($CINF) had a predictive moving average crossover to the upside in mid-July indicating a bullish trend. Additionally, the VantagePoint Neural Index moved to a “one” position indicating short term strength within the next 48 hours. Since that crossover, the market was up 10.98% in 17 trading days or $7.94 per share. The blue line has not crossed below the black line so traders can expect this bullish trend to continue and they can continue to go long.
Medtronic ($MDT) had a predictive moving average crossover to the downside in late June indicating a bearish trend. The Neural Index also moved into the zero position confirming the trend’s weakness. Traders were able to short this market for profit using the VantagePoint predictive next day highs and lows. In 28 trading days, $MDT was down 5.55%, or $4.93 per share.
Best Buy ($BBY) had a crossover to the upside in late-July and the Neural Index moved to a “one” position indicating that the market was expected to strengthen over the short. This is a clear indication to traders that they can start going long in this market.
Pacira Pharmaceuticals ($PCRX) had a bearish crossover in July indicating to traders they could start taking short. The Neural Index also moved to a “zero” position indicating short-term weakness in this particular market. In 17 trading days, the market was down $12.80 per share or over 25%.
Ubiquiti Networks ($UBNT) had a bullish crossover to the upside in mid-July. Despite some sideways movement, that blue line never crossed below the black line so traders knew the trend wasn’t over. In 15 trading days, the market was up over 27%, or $14.37 per share.
Watch the Full Techncial ANalysis Video on these stocks HERE >>>
This Week’s Hot Stocks Outlook
Cincinnati Financial ($CINF) had a predictive moving average crossover to the upside in mid-July indicating a bullish trend. Additionally, the VantagePoint Neural Index moved to a “one” position indicating short term strength within the next 48 hours. Since that crossover, the market was up 10.98% in 17 trading days or $7.94 per share. The blue line has not crossed below the black line so traders can expect this bullish trend to continue and they can continue to go long.
Medtronic ($MDT) had a predictive moving average crossover to the downside in late June indicating a bearish trend. The Neural Index also moved into the zero position confirming the trend’s weakness. Traders were able to short this market for profit using the VantagePoint predictive next day highs and lows. In 28 trading days, $MDT was down 5.55%, or $4.93 per share.
Best Buy ($BBY) had a crossover to the upside in late-July and the Neural Index moved to a “one” position indicating that the market was expected to strengthen over the short. This is a clear indication to traders that they can start going long in this market.
Pacira Pharmaceuticals ($PCRX) had a bearish crossover in July indicating to traders they could start taking short. The Neural Index also moved to a “zero” position indicating short-term weakness in this particular market. In 17 trading days, the market was down $12.80 per share or over 25%.
Ubiquiti Networks ($UBNT) had a bullish crossover to the upside in mid-July. Despite some sideways movement, that blue line never crossed below the black line so traders knew the trend wasn’t over. In 15 trading days, the market was up over 27%, or $14.37 per share.
Watch the Full Techncial ANalysis Video on these stocks HERE >>>
Complete Stock Valuation Report for $NKE
Dowload Full Report on the below on $NKE for FREE HERE >>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Complete Stock Valuation Report for $NKE
Dowload Full Report on the below on $NKE for FREE HERE >>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Bristow Group Inc $BRS is the stocks Trade of the Week
The Trade Ideas scan labeled “Trend Change Lubricant” is pointing towards a wonderful short squeeze opportunity with a chart pattern emerging from an exceptionally tight range and basing formation. Bristow Group $BRS just had earnings and the company surprised with better than expected results.
The percentage of short sellers in this stock is a whopping 64% and they will have to decide what to do if BRS breaks out of this long tight basing range. If they decide to cover their shorts by buying the stock back, we could see a nice short squeeze higher. With a relatively low float of shares in circulation (32 million), we see even more reason for continuation out of this tight range.
Get the Charts and Full Stocks trading Setup HERE >>>>
Bristow Group Inc $BRS is the stocks Trade of the Week
The Trade Ideas scan labeled “Trend Change Lubricant” is pointing towards a wonderful short squeeze opportunity with a chart pattern emerging from an exceptionally tight range and basing formation. Bristow Group $BRS just had earnings and the company surprised with better than expected results.
The percentage of short sellers in this stock is a whopping 64% and they will have to decide what to do if BRS breaks out of this long tight basing range. If they decide to cover their shorts by buying the stock back, we could see a nice short squeeze higher. With a relatively low float of shares in circulation (32 million), we see even more reason for continuation out of this tight range.
Get the Charts and Full Stocks trading Setup HERE >>>>
Facebook $FB:NAS and Anheuser-Busch InBev $BUD:NYS amongst Upgraded Stocks
Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX
Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.
Why Do Companies Get Upgraded?
Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.
In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.
Lets look at a couple of the companies on this list to get a better understanding of them.
$FB:NAS Facebook
http://www.facebook.com Facebook has 20658 employees and is headquartered in United States. Facebook Inc is the world's largest online social network. Its products are Facebook, Instagram, Messenger, WhatsApp, and Oculus. Its products enable people to connect and share through mobile devices and personal computers.
$BUD:NYS Anheuser-Busch InBev
http://www.ab-inbev.com Anheuser-Busch InBev has 200000 employees and is headquartered in Belgium. Anheuser-Busch InBev SA/NV is engaged in the production, marketing, and distribution of beer and other malt beverage brands. Its brands includes Budweiser, Corona, Stella Artois, Beck's, Leffe, Hoegaarden, Castle Lager and others.
Get the Full Valutation report list for Upgraded Stocks Today HERE >>>
Facebook $FB:NAS and Anheuser-Busch InBev $BUD:NYS amongst Upgraded Stocks
Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX
Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.
Why Do Companies Get Upgraded?
Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.
In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.
Lets look at a couple of the companies on this list to get a better understanding of them.
$FB:NAS Facebook
http://www.facebook.com Facebook has 20658 employees and is headquartered in United States. Facebook Inc is the world's largest online social network. Its products are Facebook, Instagram, Messenger, WhatsApp, and Oculus. Its products enable people to connect and share through mobile devices and personal computers.
$BUD:NYS Anheuser-Busch InBev
http://www.ab-inbev.com Anheuser-Busch InBev has 200000 employees and is headquartered in Belgium. Anheuser-Busch InBev SA/NV is engaged in the production, marketing, and distribution of beer and other malt beverage brands. Its brands includes Budweiser, Corona, Stella Artois, Beck's, Leffe, Hoegaarden, Castle Lager and others.
Get the Full Valutation report list for Upgraded Stocks Today HERE >>>
Complete Stock Valuation Report foe $DIS
Dowload Full Report on the below on $DIS for FREE HERE >>>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Complete Stock Valuation Report foe $DIS
Dowload Full Report on the below on $DIS for FREE HERE >>>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
LONG Stocks Trading Idea of week is $SIRI
This can be setting up for a go-pause-go pattern, and a breach of the 2-day high could cause the roughly 18% of the shares in the float who are short, to rush to cover. There is now a very strong support level at $5.50, but giving some wiggle-room, we will use a break of $5.45 as the stop. We always say targets are subjective, so we are calling for a 3 to 1 reward/risk ratio. With that ratio, our target will be set at $6.92
Get the Charts and Full Setup including Stop Loss HERE >>>
LONG Stocks Trading Idea of week is $SIRI
This can be setting up for a go-pause-go pattern, and a breach of the 2-day high could cause the roughly 18% of the shares in the float who are short, to rush to cover. There is now a very strong support level at $5.50, but giving some wiggle-room, we will use a break of $5.45 as the stop. We always say targets are subjective, so we are calling for a 3 to 1 reward/risk ratio. With that ratio, our target will be set at $6.92
Get the Charts and Full Setup including Stop Loss HERE >>>
Diana Containerships $DCIX:NAS and CHF Solutions $CHFS:NAS Are Biggest Stock Decliners YTD on NASDAQ
Biggest Stock Decliners Year to Date on NASDAQ
Today we are looking at companies that have had the greatest percentage decrease in share price year to date.
Bottom 25 Companies
Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic decreases in share price can do so for a variety of reasons including, the sector they are in has turned (such as companies in an unfavorable commodities space or a sector that has been disrupted), or the company is experiencing financial difficulties generally due to an inability to service its debt.
In this list we have selected the top 25 companies based on their percentage decrease in share price year to date.
Get the Full list of Biggest Stock Decliners on Nasdaq on our Daily Stock Valuation Report HERE >>>>
Diana Containerships $DCIX:NAS and CHF Solutions $CHFS:NAS Are Biggest Stock Decliners YTD on NASDAQ
Biggest Stock Decliners Year to Date on NASDAQ
Today we are looking at companies that have had the greatest percentage decrease in share price year to date.
Bottom 25 Companies
Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic decreases in share price can do so for a variety of reasons including, the sector they are in has turned (such as companies in an unfavorable commodities space or a sector that has been disrupted), or the company is experiencing financial difficulties generally due to an inability to service its debt.
In this list we have selected the top 25 companies based on their percentage decrease in share price year to date.
Get the Full list of Biggest Stock Decliners on Nasdaq on our Daily Stock Valuation Report HERE >>>>>
Summertime Trading
Summertime trading time again! Is it good or bad? Neither really. What trader need to understand is that summertime trading is just different. For newer traders, it could spell large losses as they fight to trade the same method in market moving differently than they are used to. There’s little question that to profit in the summertime something has to change and unfortunately for us, we are the ones that have to change our approach.
Grains traders are better equipped at changing their trading to meet ever-changing conditions, such as the seasons and the weather, which can have a dramatic effect on the markets they trade. For everyone, the summertime trading is a challenge. People are on vacation. Volume and volatility are low. Markets are choppy and directionless.
Get the Summertime Trading Strategy and wathc the two two videos www.mytradingbuddy.com/blog/futures/summertime-trading/[tagHERE >>>>[/tag]
Boeing $BA:NYS and BHP Billiton $BHP:NYS Are amongst Fully Valued Stocks
Fully Valued Stocks on NYSE
Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.
In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Get the Full REport of Fully Values NYSE Stocks HERE >>>
Boeing $BA:NYS and BHP Billiton $BHP:NYS Are amongst Fully Valued Stocks
Fully Valued Stocks on NYSE
Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.
In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Get the Full REport of Fully Values NYSE Stocks HERE >>>
JNJ Q2 Earnings explored
There are often deeper facts underlying earnings reports, and $JNJ Johnson & Johnson’s Q2 earnings report is no different.
What the JNJ Q2 Earnings Tell On the Surface
image of JNJ logoJohnson & Johnson (JNJ) released its Q2 earnings results on Tuesday, July 18, 2017 with profits that were beyond expectations and sales that were below anticipation. Specifically, JNJ reported global sales of $18.84 billion while the market expectation was $18.97 billion. However, the sales figure did represent a 1.9% rise from the corresponding quarter of the previous year. Without currency fluctuations, that would translate to a 2.9% rise.
JNJ reported $1.83 earnings per share which exceeded the market estimates by $0.03 per share. It has managed to top EPS estimates of the Street in every single quarter for over three years. It also improved its full-year EPS forecast to the $7.15-to-$7.22 range from the previous $7-to-$7.15, with the company being usually conservative with regard to its full-year profit guidance. But experts dig deep beneath the headlines and reveal there’s a lot more to the company’s second quarter.
Lower US Pharmaceutical Sales
Leaving out currency fluctuations, Johnson & Johnson’s pharmaceutical segment experienced 1% growth globally, and this was accounted for by increased sales overseas. Within the United States, pharmaceutical sales actually fell 2.6%. Global pharmaceutical revenue made up almost 46% of the company’s total sales in Q2. Remember, the pharmaceutical segment is the company’s primary source of growth and margins. Investors would therefore be wondering why its pharmaceutical sales have struggled in the United States.
This domestic struggle in pharmaceutical sales can be accounted for by the competition faced by mature drugs from biosimilar drugs and generics. As a result of this decline in domestic sales, Johnson & Johnson has been busy acquiring organizations. It recently completed the $30 billion cash acquisition of Actelion, the Swiss-based specialty drug manufacturer. Here the company is banking on the growth in sales of the pulmonary arterial hypertension drugs developed by Actelion for counterbalancing the weak sales from Johnson & Johnson’s mature drugs.
Get More like this on the MY Trading Buddy Online Markets Analysis Magazine HERE >>>>>
JNJ Q2 Earnings explored
There are often deeper facts underlying earnings reports, and $JNJ Johnson & Johnson’s Q2 earnings report is no different.
What the JNJ Q2 Earnings Tell On the Surface
image of JNJ logoJohnson & Johnson (JNJ) released its Q2 earnings results on Tuesday, July 18, 2017 with profits that were beyond expectations and sales that were below anticipation. Specifically, JNJ reported global sales of $18.84 billion while the market expectation was $18.97 billion. However, the sales figure did represent a 1.9% rise from the corresponding quarter of the previous year. Without currency fluctuations, that would translate to a 2.9% rise.
JNJ reported $1.83 earnings per share which exceeded the market estimates by $0.03 per share. It has managed to top EPS estimates of the Street in every single quarter for over three years. It also improved its full-year EPS forecast to the $7.15-to-$7.22 range from the previous $7-to-$7.15, with the company being usually conservative with regard to its full-year profit guidance. But experts dig deep beneath the headlines and reveal there’s a lot more to the company’s second quarter.
Lower US Pharmaceutical Sales
Leaving out currency fluctuations, Johnson & Johnson’s pharmaceutical segment experienced 1% growth globally, and this was accounted for by increased sales overseas. Within the United States, pharmaceutical sales actually fell 2.6%. Global pharmaceutical revenue made up almost 46% of the company’s total sales in Q2. Remember, the pharmaceutical segment is the company’s primary source of growth and margins. Investors would therefore be wondering why its pharmaceutical sales have struggled in the United States.
This domestic struggle in pharmaceutical sales can be accounted for by the competition faced by mature drugs from biosimilar drugs and generics. As a result of this decline in domestic sales, Johnson & Johnson has been busy acquiring organizations. It recently completed the $30 billion cash acquisition of Actelion, the Swiss-based specialty drug manufacturer. Here the company is banking on the growth in sales of the pulmonary arterial hypertension drugs developed by Actelion for counterbalancing the weak sales from Johnson & Johnson’s mature drugs.
Get More like this on the MY Trading Buddy Online Markets Analysis Magazine HERE >>>>>
Infosys $INFY:NYS and Enel Americas $ENIA:NYS amongst stocks Trading at Less than Cash Value
Trading at Less than Cash Value
Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.
What this Means...
Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.
Lets look at a couple of the companies on this list to get a better understanding of them.
$INFY:NYS Infosys
http://www.infosys.com Infosys has 200364 employees and is headquartered in India. Infosys Ltd is engaged in consulting, technology, outsourcing and next-generation services. It offers software re-engineering, maintenance, systems integration, package evaluation and implementation and infrastructure management services.
$ENIA:NYS Enel Americas
http://www.enersis.cl Enel Americas has 10324 employees and is headquartered in Chile. Enel Americas SA, generates, transmits and distributes electric energy in Chile, Argentina, Brazil, Colombia and Peru.
Get the Full Report HERE >>>
Infosys $INFY:NYS and Enel Americas $ENIA:NYS amongst stocks Trading at Less than Cash Value
Trading at Less than Cash Value
Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.
What this Means...
Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.
Lets look at a couple of the companies on this list to get a better understanding of them.
$INFY:NYS Infosys
http://www.infosys.com Infosys has 200364 employees and is headquartered in India. Infosys Ltd is engaged in consulting, technology, outsourcing and next-generation services. It offers software re-engineering, maintenance, systems integration, package evaluation and implementation and infrastructure management services.
$ENIA:NYS Enel Americas
http://www.enersis.cl Enel Americas has 10324 employees and is headquartered in Chile. Enel Americas SA, generates, transmits and distributes electric energy in Chile, Argentina, Brazil, Colombia and Peru.
Get the Full Report HERE >>>
Learn How to Use the Darvas Box Trading Indicator
Like other trading strategies, the Darvas Box is a break out momentum strategy. Developed in 1956 by ballroom dancer Nicolas Darvas, this strategy enabled him to turn a $10,000 investment into $2,000,000 over 18 months. Naysayers attributed his success to the bull market that existed at the time, and were quick to say that similar results couldn’t have been achieved in a bear market. It is also said that Darvas achieved peace of mind from following his strategy, and was less hyped about the money that he made.
The Darvas Box uses fundamental analysis to determine which stocks to buy or sell, and technical analysis to determine when to trigger the trade and when to exit the market. Darvas’ fundamental philosophy was to invest in growth stocks. He looked at an increase in volume for confirmation in industries that he expected to grow. Then, he used the Darvas Box method for his entry and exit strategy.
Even though Darvas used this method for his stock portfolio, this indicator can be used on any trending market. In the S&P Daily Chart below, the Darvas Box is automatically drawn with bullish price action.
Learn How to use this indicator with real chart examples HERE >>>>
Unilever ($UN:NYS) and Mastercard ($MA:NYS) amongst Upgraded Stocks
Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX
Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.
Why Do Companies Get Upgraded?
Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.
In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.
Today's Data on NYSE, NASDAQ, AMEX, TSE, and TSX
Below we have today's data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.
Get the full List of Upgraded Stocks HERE >>>
Unilever ($UN:NYS) and Mastercard ($MA:NYS) amongst Upgraded Stocks
Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX
Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.
Why Do Companies Get Upgraded?
Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.
In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.
Today's Data on NYSE, NASDAQ, AMEX, TSE, and TSX
Below we have today's data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.
Get the full List of Upgraded Stocks HERE >>>
Complete Stock Valuation Report foe $NFLX
Dowload Full Report on the below on $NFLX for FREE HERE >>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Complete Stock Valuation Report foe $NFLX
Dowload Full Report on the below on $NFLX for FREE HERE >>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary
Stocks Trading Idea of the Week is for Sunrun Inc |$RUN
In the interest in staying with what has been working, Trade ideas technology is giving us a few contenders that look to push to new 52 week highs with the help of short sellers capitulating and creating yet another short squeeze in this market environment. Sunrun Inc. (RUN) has caught our eye as such a candidate from the “Squeeze Me” scan. – for the stocks trading idea of the week.
The suggested entry price of buying RUN is conditional of the stock trading above 7.35 this week.
RUN has earnings in 11 trading days and also a short float of 28%; meaning 28% of the stock holders might start buying their shares back if RUN trades too far above 7.35. This could potentially propel RUN higher over a few days of “short squeezing” the short sellers.
Get the Full Setup for $RUN including Stop Loss HERE >>>
Stocks Trading Idea of the Week is for Sunrun Inc |$RUN
In the interest in staying with what has been working, Trade ideas technology is giving us a few contenders that look to push to new 52 week highs with the help of short sellers capitulating and creating yet another short squeeze in this market environment. Sunrun Inc. (RUN) has caught our eye as such a candidate from the “Squeeze Me” scan. – for the stocks trading idea of the week.
The suggested entry price of buying RUN is conditional of the stock trading above 7.35 this week.
RUN has earnings in 11 trading days and also a short float of 28%; meaning 28% of the stock holders might start buying their shares back if RUN trades too far above 7.35. This could potentially propel RUN higher over a few days of “short squeezing” the short sellers.
Get the Full Setup for $RUN including Stop Loss HERE >>>
Next Week’s Hot Stocks Outlook
OraSure Technologies ($OSUR) had a predictive moving average crossover to the upside in late June indicating a bullish trend. Additionally, the VantagePoint neural index moved to a “one” position. This indicated to traders that there was short-term 48-hour strength in that market. Since that crossover, the market was up 20.41% in 17 trading days or $3.17 per share.
Rockwell Medical ($RMTI) had a predictive moving average crossover to the downside indicating a bearish trend. The Neural Index also moved into the zero position. Traders were able to short this market for profit using VantagePoint’s expected next day highs and lows.
Wabash National Corp ($WNC) had a crossover to the upside in early-June and the neural index moved to a “one” position indicating that the market was expected to strengthen over the short term. In the 28 trading days, the market was up 8.25% or $1.73 per share.
Harley Davidson ($HOG) had a bearish crossover in June. The neural index moved to a “zero” position and that bearish weakness continued despite some sideways movement. In 15 trading days, the market was down $6.25 per share or 11.36%.
Wipro ($WIT) also had a bullish crossover in mid-June and the neural index moved into the “one” position. In 17 trading days, the market was up almost 8% or $0.37 per share.
Wacth the complate Video Analysis for these Hot Stocks HERE >>>>
Next Week’s Hot Stocks Outlook
OraSure Technologies ($OSUR) had a predictive moving average crossover to the upside in late June indicating a bullish trend. Additionally, the VantagePoint neural index moved to a “one” position. This indicated to traders that there was short-term 48-hour strength in that market. Since that crossover, the market was up 20.41% in 17 trading days or $3.17 per share.
Rockwell Medical ($RMTI) had a predictive moving average crossover to the downside indicating a bearish trend. The Neural Index also moved into the zero position. Traders were able to short this market for profit using VantagePoint’s expected next day highs and lows.
Wabash National Corp ($WNC) had a crossover to the upside in early-June and the neural index moved to a “one” position indicating that the market was expected to strengthen over the short term. In the 28 trading days, the market was up 8.25% or $1.73 per share.
Harley Davidson ($HOG) had a bearish crossover in June. The neural index moved to a “zero” position and that bearish weakness continued despite some sideways movement. In 15 trading days, the market was down $6.25 per share or 11.36%.
Wipro ($WIT) also had a bullish crossover in mid-June and the neural index moved into the “one” position. In 17 trading days, the market was up almost 8% or $0.37 per share.
Wacth the complate Video Analysis for these Hot Stocks HERE >>>>
Complete Stock Valuation Report foe $CAT
Dowload Full Report on the below on $CAT for FREE HERE >>>>
Discounted Cash Flow
Company Overview
Financial Data
Ratio Data
Valuation Details and Assumptions
Analyst Coverage
Forecasted Financial Statements
Comparable Companies
Multiples Approach
Adjusted Book Value versus Historical Price to Book
Sector and Industry Analysis
Summary